QA: Arena Pharmaceuticals INC in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001080709_2019_Arena_Pharmaceuticals_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001080709, Arena Pharmaceuticals INC

  xvar xval
0 AssetsCurrent 460,725,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 23,114,000
3 remainder_Assets 203,064,000
4 LiabilitiesCurrent 29,918,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 49,370,174
9 ResearchAndDevelopmentExpense 115,446,703
10 remainder_Expenses -719,926,739
11 remainder_Revenues 18,985,162
12 remainder_NetIncome 4,520,901
13 remainder_ComprehensiveNetIncome 75,060
  yvar yval
0 Assets 686,903,000
1 Liabilities 29,918,000
2 Expenses -555,109,862
3 Revenues 18,985,162
4 StockholdersEquity 656,985,000
5 NetIncome 578,615,925
6 ComprehensiveNetIncome 578,653,455
7 BaseVar 647,755,992
8 EconomicCapitalRatiobeforeLimitedLiability 5.61
9 EconomicCapitalRatio 5.72

Edgar->Model Mapping

Feature Distribution

Change over Time